Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
37m
Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight
Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...
BioSpace
52m
GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome Warnings
A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfires
Altman denies sister's claims
Alaska sues Biden admin
Louisiana mayor arrested
Considering governor run
Finalize their divorce
Laken Riley Act passed
Inmates reject clemency
Pleads not guilty
Driver pleads not guilty
New allegations emerge
Folk legend Yarrow dies
Former Orioles pitcher dies
Antisemitic threats arrest
Bodies found in landing gear
Tesla faces US probe
Sanctioned for corruption?
Testifies in corruption trial
Job openings rise
DOJ suing 6 major landlords
Biden signs RFK Stadium bill
French far-right leader dies
Overhauls Mars sample plan
US trade deficit widens
Online holiday sales rise
GenAI used to plan attack
CFPB sues Experian
Files motion to dismiss case
Remains arrive in D.C.
Court rejects latest attempt
CFTC chairman to step down
Israeli raids in West Bank
Related topics
GSK
New York Stock Exchange
Food and Drug Administration
Breakthrough therapy
Bone tumor
Feedback